Skip to main content
University of California San Francisco
UCSF School of Medicine | Department of Pediatrics UCSF Medical Center

Long ncRNA Landscape in the Ileum of Treatment-Naive Early-Onset Crohn Disease.

  • Read more about Long ncRNA Landscape in the Ileum of Treatment-Naive Early-Onset Crohn Disease.

Subcutaneous Golimumab in Pediatric Ulcerative Colitis: Pharmacokinetics and Clinical Benefit.

  • Read more about Subcutaneous Golimumab in Pediatric Ulcerative Colitis: Pharmacokinetics and Clinical Benefit.

Rapid Infliximab Infusion in Children with Inflammatory Bowel Disease: A Multicenter North American Experience.

  • Read more about Rapid Infliximab Infusion in Children with Inflammatory Bowel Disease: A Multicenter North American Experience.

Utility of neutrophil Fc? receptor I (CD64) index as a biomarker for mucosal inflammation in pediatric Crohn's disease.

  • Read more about Utility of neutrophil Fc? receptor I (CD64) index as a biomarker for mucosal inflammation in pediatric Crohn's disease.

Determination of bone age in pediatric patients with Crohn's disease should become part of routine care.

  • Read more about Determination of bone age in pediatric patients with Crohn's disease should become part of routine care.

Sex differences in statural growth impairment in Crohn's disease: role of IGF-1.

  • Read more about Sex differences in statural growth impairment in Crohn's disease: role of IGF-1.

ImproveCareNow: The development of a pediatric inflammatory bowel disease improvement network.

  • Read more about ImproveCareNow: The development of a pediatric inflammatory bowel disease improvement network.

Prevalence and epidemiology of overweight and obesity in children with inflammatory bowel disease.

  • Read more about Prevalence and epidemiology of overweight and obesity in children with inflammatory bowel disease.

Transitioning the adolescent inflammatory bowel disease patient: guidelines for the adult and pediatric gastroenterologist.

  • Read more about Transitioning the adolescent inflammatory bowel disease patient: guidelines for the adult and pediatric gastroenterologist.

Efficacy and safety of mesalamine suppositories for treatment of ulcerative proctitis in children and adolescents.

  • Read more about Efficacy and safety of mesalamine suppositories for treatment of ulcerative proctitis in children and adolescents.

Pagination

  • Previous page ‹‹
  • Page 2
  • Next page ››
Subscribe to Inflammatory bowel diseases

Pediatrics Home

MAKE A GIFT

© 2022 The Regents of the University of California. The University of California San Francisco  |  UCSF Department of Pediatrics                                                                                              Accessibility  Privacy Policy  Terms of Use  A-Z Website List